Literature DB >> 19699919

Standard uptake value predicts survival in non-small cell lung cancer.

Ikenna C Okereke1, Sidhu P Gangadharan, Michael S Kent, Saila P Nicotera, Changyu Shen, Malcolm M DeCamp.   

Abstract

BACKGROUND: Integrated [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) scan is a widely used modality in the evaluation of lung cancer. Our goal was to determine the ability of the standard uptake value (SUV) of the primary tumor (SUV-T) and regional lymph nodes (SUV-N) to predict survival.
METHODS: From January 2005 through June 2007, 584 consecutive patients undergoing integrated PET-CT scan for suspected lung cancer were studied. Results of integrated PET-CT scans, including the maximum SUV-T and SUV-N, were recorded. A patient was defined as having a positive PET scan if the maximum SUV (T or N) was greater than 2.5. Overall survival was documented from clinical records and the Social Security Death Index. Cox regression analysis was used to evaluate the correlation between SUV and survival.
RESULTS: Among patients with a positive PET scan (n = 329), both SUV-T and SUV-N were predictors of survival. As maximum SUV of the primary mass increased, survival decreased (hazard ratio, 1.05; p < 0.001). As maximum SUV of locoregional lymph nodes increased, survival also decreased (hazard ratio, 1.06; p < 0.001). Furthermore, among patients with no mediastinal disease identified by PET-CT scan, increased SUV-T continued to predict poor survival (hazard ratio, 1.06; p = 0.001).
CONCLUSIONS: Local and regional maximum SUVs defined by integrated PET-CT scanning have a strong correlation with survival in patients with non-small cell lung cancer. An elevated SUV is known preoperatively and may assist clinicians in stratifying patients at increased overall risk preoperatively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19699919     DOI: 10.1016/j.athoracsur.2009.05.083

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Feasibility of cetuximab and chemoradiotherapy combination in Chinese patients with unresectable stage III non-small cell lung cancer: a preliminary report.

Authors:  Di Liu; Yu-Xin Shen; Wei-Xin Zhao; Guo-Liang Jiang; Jia-Yan Chen; Min Fan
Journal:  Chin J Cancer Res       Date:  2015-04       Impact factor: 5.087

Review 2.  Doctor, what does my future hold? The prognostic value of FDG-PET in solid tumours.

Authors:  Giovanni Lucignani; Steven M Larson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05       Impact factor: 9.236

3.  Comparison of prognostic values of primary tumor and nodal 18F-fluorodeoxyglucose uptake in non-small cell lung cancer with N1 disease.

Authors:  Chae Hong Lim; Seung Hyup Hyun; Seung Hwan Moon; Young Seok Cho; Joon Young Choi; Kyung-Han Lee
Journal:  Eur Radiol       Date:  2019-03-21       Impact factor: 5.315

4.  Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.

Authors:  Yoichi Ohtaki; Kimihiro Shimizu; Kyoichi Kaira; Toshiteru Nagashima; Kai Obayashi; Seshiru Nakazawa; Seiichi Kakegawa; Hitoshi Igai; Mitsuhiro Kamiyoshihara; Masahiko Nishiyama; Izumi Takeyoshi
Journal:  Surg Today       Date:  2016-01-19       Impact factor: 2.549

5.  Axillary Lymph Node-to-Primary Tumor Standard Uptake Value Ratio on Preoperative (18)F-FDG PET/CT: A Prognostic Factor for Invasive Ductal Breast Cancer.

Authors:  Young Hwan Kim; Hai-Jeon Yoon; Yemi Kim; Bom Sahn Kim
Journal:  J Breast Cancer       Date:  2015-06-26       Impact factor: 3.588

6.  Liquid biopsy-based single-cell metabolic phenotyping of lung cancer patients for informative diagnostics.

Authors:  Ziming Li; Zhuo Wang; Yin Tang; Xiang Lu; Jie Chen; Yu Dong; Baojun Wu; Chunying Wang; Liu Yang; Zhili Guo; Min Xue; Shun Lu; Wei Wei; Qihui Shi
Journal:  Nat Commun       Date:  2019-08-26       Impact factor: 14.919

7.  Determination of prognostic factors of surgically treated pathological Stage IIIA non-small cell lung cancer.

Authors:  Muhammet Sayan; Elgun Valiyev; Merve Satır Türk; Aynur Baş; Ali Çelik; İsmail Cüneyt Kurul; Olgun Kadir Arıbaş; Abdullah İrfan Taştepe
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-07-28       Impact factor: 0.332

8.  Spontaneous regression of non-small cell lung cancer that progressed after multiple chemotherapies: A case report.

Authors:  Chaeuk Chung; Dong Il Park; Sun Young Kim; Ju Ock Kim; Sung Soo Jung; Hee Sun Park; Jae Young Moon; Sung Min Kim; Min Ji Cho; Sang Ok Jung; Choong Sik Lee; Jeong Eun Lee
Journal:  Thorac Cancer       Date:  2015-01-29       Impact factor: 3.500

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.